:

NOVO NORDISK DISCLOSES CLINICAL TRIALS DATA BREACH

SECURITY DESK1 MIN READ
FRI, JUN 12, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

Danish pharmaceutical giant Novo Nordisk has disclosed a data breach affecting patient information from clinical trials. The company is the world's largest insulin producer.

Novo Nordisk confirmed the breach impacted personal data linked to some of its clinical trial programs. The company said it discovered unauthorized access to patient information and is investigating the scope and nature of the incident. The breach raises questions about data security practices in pharmaceutical research. Clinical trial data typically includes sensitive medical records, personal identifiers, and health histories. Novo Nordisk stated it is working with cybersecurity experts and notifying relevant regulatory authorities. The company has not disclosed the number of affected patients or specific details about what information was accessed. This incident follows broader concerns about data protection in the healthcare sector. Regulatory bodies including the FDA and European Medicines Agency oversee clinical trial data security standards. Novo Nordisk produces insulin and other diabetes treatments serving millions of patients globally. The company has not yet announced remediation measures or timelines for affected trial participants.

■ SOURCES

Bleeping Computer

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE SECURITY DESK

Security researchers discovered 21 previously unknown vulnerabilities in FFmpeg, the widely-used multimedia framework. The findings raise concerns about the security posture of a project relied upon by millions of applications.

1H AGOSecurity Desk

An unnamed British police officer faces criminal investigation for allegedly using artificial intelligence to create evidence in multiple cases. The officer has been removed from frontline duties in what authorities describe as the first known case of its kind in the UK.

9H AGOAI Desk

A growing market of DIY gadgets in China allows drivers to circumvent Tesla's distracted-driving safeguards. Tiny plastic heads, blinking screens, and celebrity figurines trick the vehicle's camera into thinking the driver is paying attention.

9H AGOIndustry Desk

Section 702 of the Foreign Intelligence Surveillance Act expires tonight, but surveillance operations will proceed under a certification that remains valid until March 2027.

9H AGOIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.